Free Stock & ETF Comparisons
2300+ side-by-side comparisons with AI scores, valuation metrics, performance charts, analyst targets, and investor takeaways. No sign-in required.
- AI investment scores (0–100) for each stock
- Valuation metrics: P/E, forward P/E, PEG, EV/EBITDA
- Performance charts across 1M to 10Y timeframes
- Analyst price targets and upside estimates
- AI-written investor thesis and side-by-side takeaways
Browse Comparisons
Compare BATT and LIT by battery material supply chain exposure, EV adoption beta, lithium miner weighting, expense ratio, and which battery technology ETF is better for playing the electrification megatrend.
Compare COPX and XME by copper vs diversified metals concentration, EV demand beta, geographic exposure (Latin America vs US), expense ratio, and which commodity mining ETF better captures the electrification-driven metals supercycle thesis.
Compare CIBR and BUG by portfolio size, top holding concentration, growth vs value tilt in cybersecurity, expense ratio, and which cybersecurity sector ETF provides more diversified exposure to network security, cloud security, and endpoint protection.
Compare IGIB and VCIT by expense ratio, underlying index, duration, credit quality tilt, and which intermediate-term investment grade corporate bond ETF is the more cost-efficient choice for fixed income allocation.
Compare EMB and PCY by USD-denominated EM sovereign debt exposure, credit quality, country concentration, yield, expense ratio, and which emerging market bond ETF is better for investors seeking EM fixed income yield with manageable risk.
Compare SPDW and VEA by expense ratio (both ~0.07%), underlying index (MSCI vs FTSE), South Korea inclusion difference, Japan/Europe weighting, and which ultra-low-cost developed market ETF is the better core international allocation.
Compare SPEM and VWO by expense ratio, MSCI vs FTSE EM index (South Korea inclusion), China weighting, small-cap exposure, and which ultra-low-cost emerging market ETF delivers better long-term risk-adjusted returns.
Compare VNQI and REET by ex-US vs global REIT coverage, Japan/Hong Kong real estate weighting, expense ratio, currency risk, and which international real estate ETF belongs in a globally diversified income portfolio.
Compare IEF and VGIT by duration targeting (7-10yr vs 5-10yr range), expense ratio, liquidity, and which intermediate US Treasury ETF is better for tactical interest rate duration management in a bond portfolio.
Compare BIL and SGOV by effective yield on ultra-short T-bills, expense ratio, liquidity, and which money market alternative Treasury ETF is the better parking spot for cash waiting to be deployed in volatile markets.
Compare Phathom Pharmaceuticals and Arrowhead Pharmaceuticals by vonoprazan acid-related disease launch, RNAi liver-targeted therapy pipeline breadth, partnership revenue, and which specialty biotech is closer to self-sustaining cash flow.
Compare Sarepta Therapeutics and Summit Therapeutics by Elevidys Duchenne gene therapy revenue, ivonescimab lung cancer partnership (Summit/Akeso), regulatory timeline, and which rare disease biotech has higher near-term catalyst value.
Compare RxSight and Amphora by light adjustable intraocular lens post-cataract revenue ramp, specialty drug delivery device market, and which niche medical device company is capturing a new surgical standard of care.
Compare Glaukos and Amedisys by iDose sustained-release glaucoma drug delivery ARR, home health visit reimbursement, hospice admission growth, and which specialty healthcare company has more durable recurring revenue.
Compare Procept BioRobotics and Silk Road Medical by AquaBeam BPH robotic surgery adoption, TCAR carotid stenting device procedure growth, and which small-cap medical device company builds the more defensible clinical procedure moat.
Compare TransMedics and Butterfly Network by Organ Care System transport device revenue, handheld ultrasound probe subscription model, and which breakthrough medical device platform is on a faster path to hospital standard of care.
Compare Stevanato Group and Envista Holdings by pharmaceutical glass vial/syringe revenue, dental implant and orthodontic equipment market share, and which healthcare supplier delivers more consistent mid-cycle organic growth.
Compare Marsh & McLennan and Aon by commercial risk consulting growth, reinsurance brokerage revenue, Oliver Wyman vs Aon Consulting, and which global insurance and risk advisory firm is better positioned for enterprise demand.
Compare W.R. Berkley and specialty property casualty insurance niche products by commercial excess and surplus lines pricing power, specialty marine/aviation/cyber underwriting, and which specialty P&C insurer has the most consistent combined ratio.
Compare RLI Corp and Kinsale Capital by excess and surplus lines specialty niche underwriting, combined ratio discipline, technology-driven pricing sophistication, and which specialty E&S insurer is the better long-term compounder.
Compare MarketAxess and BGC Partners by electronic credit bond trading share vs voice broker revenue, Open Trading protocol adoption, interest rate derivatives revenue, and which financial intermediary benefits more from electronic market evolution.
Compare Saul Centers and Gladstone Land by DC metro grocery-anchored retail NOI, farmland lease income, food security investment thesis, and which niche REIT provides more predictable income in an inflationary environment.
Compare Main Street Capital and Ares Capital by monthly vs quarterly dividend, lower middle market vs large market lending, net investment income yield, NAV per share trajectory, and which BDC is safer for income-oriented portfolios.
Compare Fastly and Cloudflare by CDN traffic revenue, edge computing compute-at-edge adoption, Cloudflare Zero Trust SASE revenue, developer platform stickiness, and which edge infrastructure company is on a better growth trajectory.
Compare Nutanix and Hewlett Packard Enterprise by VMware migration customer win rate, GreenLake as-a-service ARR, HCI appliance vs software-only revenue mix, and which hybrid cloud infrastructure platform captures more enterprise spend.
Compare C3.ai and Samsara by AI application suite ARR, IoT fleet telematics subscription, government vs commercial revenue mix, path to profitability, and which enterprise AI platform has a more credible business model.
Compare Palantir and C3.ai by AIP/Foundry commercial contract growth, C3 generative AI application revenue, customer count trajectory, operating margin improvement, and which enterprise AI software company has earned its premium valuation.
Compare Microsoft Azure and Google Cloud Platform by AI/ML workload share, OpenAI partnership monetisation, Google Gemini integration, enterprise contract growth, and which hyperscale cloud platform wins the enterprise AI migration wave.
Compare Amazon Web Services and Microsoft Azure by revenue growth rate, operating margin, AI accelerator availability, hybrid cloud enterprise penetration, and which cloud platform is better positioned as AI workloads become the dominant growth driver.
Compare Hewlett Packard Enterprise and Cisco Systems by Ethernet AI networking revenue (HPE Slingshot), Catalyst/Nexus switch campus vs data center, GreenLake ARR, and which traditional network infrastructure company pivots fastest to AI.
Compare NCR Voyix and PAR Technology by restaurant POS SaaS ARR, omnichannel retail platform migration, PAR Brink POS cloud adoption, and which point-of-sale technology company transitions faster to a software subscription model.
Compare Olo and PAR Technology by restaurant digital ordering SaaS ARR, Rails payment processing revenue, Olo Pay adoption, and which restaurant technology platform builds the deeper integration with major QSR chains.
Compare RingCentral and 8x8 by UCaaS seat growth, AI-powered contact center upsell, Microsoft Teams co-existence strategy, net revenue retention, and which cloud communication platform is the better value after valuation compression.
Compare Domo's cloud BI platform ARR vs Microsoft Power BI's embedded enterprise advantage, AI-powered data storytelling, and which dedicated BI platform survives as Microsoft bundles analytics into M365.
Compare AppFolio and Yext by property management software ARPU, AI-powered answers platform for enterprise search, customer net revenue retention, and which niche B2B SaaS platform has the more defensible vertical moat.
Compare Portillo's and Darden Restaurants by unit economics, same-restaurant sales growth, Portillo's limited market expansion opportunity vs Darden's Olive Garden/LongHorn moat, and which restaurant operator is the better compounding investment.
Compare BJ's Restaurants and Texas Roadhouse by beer/restaurant combo traffic driver, menu price elasticity, labor cost as % of revenue, and which casual dining chain delivers more consistent comparable restaurant sales growth.
Compare Six Flags (now merged with Cedar Fair as United Parks & Resorts) by season pass revenue, attendance, park capex investment, merger synergy realisation, and how the combined entity positions against Disney/Universal theme parks.
Compare SeaWorld Entertainment and United Parks & Resorts by per capita in-park spending, season pass attachment, animal care/ESG reputational impact, and which regional theme park operator is better positioned for travel recovery.
Compare Winnebago Industries and LCI Industries by RV aftermarket parts recurring revenue, new motorhome vs towable unit mix, dealer inventory normalisation, and which RV industry stock is more insulated from consumer sentiment swings.
Compare Harley-Davidson and Topgolf Callaway Brands by lifestyle brand pricing power, younger demographic acquisition, Topgolf entertainment venue EBITDA, LiveWire electric motorcycle adoption, and which aspirational leisure brand compounds better.
Compare ModivCare and Amphenol by NEMT Medicaid managed care contract revenue, high-speed connector revenue for AI data centers, and which services/industrials company has more predictable recurring mid-cycle revenue.
Compare PTC Therapeutics and TriplePoint Venture Growth by rare disease drug (Translarna/Upstaza) launch trajectory, venture lending BDC net investment income, and which smaller income/growth security is more suitable for an income-growth barbell portfolio.
Compare CareTrust REIT and Omega Healthcare Investors by skilled nursing and assisted living facility coverage ratio, dividend safety, acquisition pipeline, operator credit quality, and which healthcare REIT is better for income investors.
Compare AMETEK and Fortive by niche electronic instrument market leadership, Fortive's recurring software tools ARR, M&A capital allocation track record, and which precision industrial compounder delivers more consistent earnings growth.
Compare Boot Barn Holdings and western apparel retail by same-store sales in work/western lifestyle boot and apparel, private label penetration, store count expansion, and which western wear retailer has the stronger brand and unit economics.
Compare Olaplex's professional bond-building hair care brand recovery, professional channel vs retail pricing dynamics, and Terra Property's commercial real estate loan portfolio health, as two very different small-cap equity stories.
Compare Celanese and LyondellBasell by acetyl chain vs polyolefin cycle exposure, engineering materials acquisition (DuPont M&M), refining segment earnings, and which chemical company is more resilient through a polymer price trough.
Sign in to access the full platform — compare any stocks, build watchlists, and get AI-powered portfolio insights.
Start Free Trial